L3-SMI as a predictor of overall survival in oesophageal cancer patients receiving PD-1 inhibitors combined with chemotherapy
Excessive muscle loss rather than muscle loss before and after administration of PD-1 inhibitors combined with chemotherapy is an important prognostic factor for therapeutic outcomes and OS in EC patients.
Authors
- Ting Mei (ORCID: https://orcid.org/0000-0003-3029-4460)
- Yuanhang He (ORCID: https://orcid.org/0000-0002-8275-7407)
- Huiya Ying
- Xian Song
- Yuxuan Zhang (ORCID: https://orcid.org/0000-0001-9407-9589)
- Shiyu Li (ORCID: https://orcid.org/0000-0002-9554-198X)
- Kanglei Ying
- Yiwen Hong
- Chenrui Yao
- Yuhao Chen (ORCID: https://orcid.org/0009-0003-0576-4712)
- Fujun Yu (ORCID: https://orcid.org/0000-0001-5321-7228)
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1080/07853890.2024.2440114
- Citations
- 2
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.65
Funders
- Wenzhou Municipal Science and Technology Bureau